Brittany G. Craiglow, MD

Expert dermatologists share final thoughts on treatment of vitiligo and topical ruxolitinib.

Experts in dermatology comment on the need to promote access to emerging treatments in vitiligo.

Heather Woolery-Lloyd, MD, and Nada Elbuluk, MD, share approaches to patient education and managing patient expectations when repigmenting the skin in vitiligo.

Expert dermatologists discuss the impact of vitiligo and vitiligo treatment on quality of life.

Nada Elbuluk, MD, and Ted Lain, MD, compare response to conventional treatment options vs emerging therapies, such as ruxolitinib, in the treatment of vitiligo.

Experts in dermatology share their impressions of ruxolitinib and approaches to vitiligo treatment in clinical practice.

Heather Woolery-Lloyd, MD, discusses the adverse event profile of topical ruxolitinib for treatment of vitiligo, highlighting the well-tolerated nature of the drug.

Expert dermatologists comment on the impact of UV light exposure on areas of the skin with vitiligo and their recommendations for sunscreen use.

Experts in dermatology review the mechanism of action and clinical trials of topical ruxolitinib for repigmenting the skin in vitiligo.

Brittany Craiglow, MD, discusses the lengthy nature of vitiligo treatment response and how to approach communicating with patients who want to see change quickly.

Ted Lain, MD, reviews the rates and patterns of repigmentation of the skin in vitiligo and how the timeline is different for each patient.

Expert dermatologists share approaches to treating patients with vitiligo, focusing on patient communication and the use of combination therapy.

Heather Woolery-Lloyd, MD, comments on the emotional impact of vitiligo on patients’ quality of life.

Ted Lain, MD, breaks down the use of the Vitiligo Area Scoring Index calculations to assess vitiligo severity.

Drs Brittany Craiglow and Nada Elbuluk review the precipitating factors that trigger vitiligo, as well as segmental vs nonsegmental vitiligo.

Experts in dermatology stress the importance of patient education in atopic dermatitis management and discuss their approaches to keeping patients up-to date.

Raj Chovatiya, MD, PhD; Brittany G. Craiglow, MD; and Peter A. Lio, MD, provide insight into emerging therapies and future directions in the management of pediatric atopic dermatitis.

Dr Peter A. Lio hypothesizes about the ability to induce remission in patients suffering from atopic dermatitis with the use of biologics and holistic treatment approaches.

Dr Brittany G. Craiglow reviews dosing considerations and nuances for the use of dupilumab for atopic dermatitis in pediatric populations.

Experts in dermatology review the indications and evolution of the use of dupilumab in patients with atopic dermatitis, highlighting its recent approval for patients 6 months and older.

Brittany G. Craiglow, MD, discusses the efficacy and safety of upadacitinib and describes her clinical experiences with this treatment.

Brittany G. Craiglow, MD, and Peter A. Lio, MD, provide insight into the efficacy and safety of currently available JAK inhibitors for the treatment of pediatric atopic dermatitis.

Raj Chovatiya, MD, PhD, highlights recent advances in pediatric atopic dermatitis treatments and discusses considerations regarding their use and indications.

Peter A. Lio, MD, describes the challenges pediatric patients face with oral therapies for atopic dermatitis, focusing on ease of administration and patient adherence.

Raj Chovatiya, MD, PhD; Brittany G. Craiglow, MD; and Peter A. Lio, MD, highlight challenges physicians face with the available atopic dermatitis treatments for pediatric patients.

Dr Peter A. Lio shares his advice for curating an atopic dermatitis treatment plan and explains the difference between rescue and maintenance treatments.

Dr Brittany G. Craiglow provides an overview of her approach to use of nonpharmacological agents in the treatment of her pediatric patients with atopic dermatitis.

Raj Chovatiya, MD, PhD, and Brittany G. Craiglow, MD, share their opinions on how they assess and what they define as treatment success in their pediatric patients suffering from atopic dermatitis.

Experts in dermatology review the treatment landscape for pediatric patients with atopic dermatitis.

Dr Brittany G. Craiglow discusses the impact of disease burden on both the patient and their caregivers, with a focus on how this burden evolves as a patient ages.